Impact of admission hyperglycemia on hospital mortality in various intensive care unit populations

被引:176
作者
Whitcomb, BW [1 ]
Pradhan, EK
Pittas, AG
Roghmann, MC
Perencevich, EN
机构
[1] Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA
[2] Tufts Univ, New England Med Ctr, Div Endocrinol, Boston, MA 02111 USA
[3] VA Maryland Healthcare Syst, Baltimore, MD USA
关键词
hyperglycemia; diabetes mellitus; intensive care unit; mortality; effect modification;
D O I
10.1097/01.CCM.0000189741.44071.25
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: Hyperglycemia in intensive care unit patients has been associated with an increased mortality rate, and institutions have already begun tight glucose control programs based on a limited number of clinical trials in restricted populations. This study aimed to assess the generalizability of the association between hyperglycemia and in-hospital mortality in different intensive care unit types adjusting for illness severity and diabetic history. Design: Retrospective cohort study. Setting: The medical, cardiothoracic surgery, cardiac, general surgical, and neurosurgical intensive care units of the University of Maryland Medical Center. Patients: Patients admitted between July 1996 and January 1998 with length of stay >= 24 hrs (n = 2713). Interventions: On intensive care unit admission, blood glucose and other physiologic variables were evaluated. Regular measurements were taken for calculation of Acute Physiology and Chronic Health Evaluation III scoring. Patients were followed through hospital discharge. Admission blood glucose was used to classify patients as hyperglycernic (> 200 mg/dL) or normoglycemic (60-200 mg/dL). The contribution of hyperglycemia to in-hospital mortality stratified by intensive care unit type and diabetes history while controlling for illness severity was estimated by logistic regression. Measurements and Main Results: The adjusted odds ratios for death comparing all patients with hyperglycemia to those without were 0.81 (95% confidence interval, 0.37,1.77) and 1.76 (95% confidence interval, 1.23, 2.53) for those with and without diabetic history, respectively. Higher mortality was seen in hyperglycemic patients without diabetic history in the cardiothoracic, (adjusted odds ratio, 2.84 [1.21, 6.63]), cardiac (adjusted odds ratio, 2.64 [1.14, 6.10]), and neurosurgical units (adjusted odds ratio, 2.96 [1.51, 5.77]) but not the medical or surgical intensive care units or in patients with diabetic history. Conclusions: The association between hyperglycemia on intensive care unit admission and in-hospital mortality was not uniform in the study population; hyperglycemia was an independent risk factor only in patients without diabetic history in the cardiac, cardiothoracic, and neurosurgical intensive care units.
引用
收藏
页码:2772 / 2777
页数:6
相关论文
共 37 条
  • [21] Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus:: a prospective study
    Norhammar, A
    Tenerz, Å
    Nilsson, G
    Hamsten, A
    Efendíc, S
    Rydén, L
    Malmberg, K
    [J]. LANCET, 2002, 359 (9324) : 2140 - 2144
  • [22] IN-HOSPITAL PROGNOSIS OF PATIENTS WITH FASTING HYPERGLYCEMIA AFTER 1ST MYOCARDIAL-INFARCTION
    OSULLIVAN, JJ
    CONROY, RM
    ROBINSON, K
    HICKEY, N
    MULCAHY, R
    [J]. DIABETES CARE, 1991, 14 (08) : 758 - 760
  • [23] INCREASED DAMAGE AFTER ISCHEMIC STROKE IN PATIENTS WITH HYPERGLYCEMIA WITH OR WITHOUT ESTABLISHED DIABETES-MELLITUS
    PULSINELLI, WA
    LEVY, DE
    SIGSBEE, B
    SCHERER, P
    PLUM, F
    [J]. AMERICAN JOURNAL OF MEDICINE, 1983, 74 (04) : 540 - 544
  • [24] Marginal structural models and causal inference in epidemiology
    Robins, JM
    Hernán, MA
    Brumback, B
    [J]. EPIDEMIOLOGY, 2000, 11 (05) : 550 - 560
  • [25] Glucose and insulin therapy in acute stroke; why delay further? Commentary
    Scott, JF
    Gray, CS
    O'Connell, JE
    Alberti, KGMM
    [J]. QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 1998, 91 (07): : 511 - 515
  • [26] Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia the Glucose Insulin in Stroke Trial (GIST)
    Scott, JF
    Robinson, GM
    French, JM
    O'Connell, JE
    Alberti, KGMM
    Gray, CS
    [J]. STROKE, 1999, 30 (04) : 793 - 799
  • [27] Molecular understanding of hyperglycemia's adverse effects for diabetic complications
    Sheetz, MJ
    King, GL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (20): : 2579 - 2588
  • [28] TORTORA GJ, 1996, PRINCIPLES ANATOMY P, P542
  • [29] Hyperglycemia: An independent marker of in-hospital mortality in patients with undiagnosed diabetes
    Umpierrez, GE
    Isaacs, SD
    Bazargan, N
    You, XD
    Thaler, LM
    Kitabchi, AE
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (03) : 978 - 982
  • [30] Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control
    Van den Berghe, G
    Wouters, PJ
    Bouillon, R
    Weekers, F
    Verwaest, C
    Schetz, M
    Vlasselaers, D
    Ferdinande, P
    Lamers, P
    [J]. CRITICAL CARE MEDICINE, 2003, 31 (02) : 359 - 366